1,418
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution

ORCID Icon &
Pages 1115-1130 | Received 22 Aug 2018, Accepted 28 Sep 2018, Published online: 23 Jan 2019

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
  • Shah PV, Rajput SJ. Facile synthesis of chitosan capped mesoporous silica nanoparticles: a pH responsive smart delivery platform for raloxifene hydrochloride. AAPS PharmSciTech. 2018;19:1344–1357.
  • Li J, Guo Y, Li H, et al. Superiority of amino-modified chiral mesoporous silica nanoparticles in delivering indometacin. Artif Cells Nanomed Biotechnol. 2018;46:1085–1094.
  • ud Din F, Aman W, Ullah I, et al. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine. 2017;12:7291.
  • Saroj S, Rajput SJ. Composite smart mesoporous silica nanoparticles as promising theranostic candidates: recent trends and applications. J Drug Deliv Sci Technol. 2018;44:349–365.
  • Zhu L, Torchilin VP. Stimulus-responsive nanopreparations for tumor targeting. Integrat Biol. 2013;5:96–107.
  • Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev. 2008;60:1615–1626.
  • Dhas NL, Ige PP, Kudarha RR. Design, optimization and in-vitro study of folic acid conjugated-chitosan functionalized PLGA nanoparticle for delivery of bicalutamide in prostate cancer. Powder Technol. 2015;283:234–245.
  • Bonvin D, Bastiaansen JA, Stuber M, et al. Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer. Dalton Trans. 2017;46:12692–12704.
  • Hattori Y, Maitani Y. Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther. 2005;12:796.
  • Martínez-Carmona M, Lozano D, Colilla M, et al. Selective topotecan delivery to cancer cells by targeted pH-sensitive mesoporous silica nanoparticles. RSC Adv. 2016;6:50923–50932.
  • Singh R, Singh S, Sharma PK, et al. T regulatory and prostate cancer cell-specific drug targeting using novel XPclad© nanoparticles (42.7). Am Assoc Immnol. 2009;182.
  • López V, Villegas MR, Rodríguez V, et al. Janus mesoporous silica nanoparticles for dual targeting of tumor cells and mitochondria. ACS Appl Mater Interfaces. 2017;9:26697–26706.
  • de Oliveira LFa, Bouchmella K, Gonçalves KA, et al. Functionalized silica nanoparticles as an alternative platform for targeted drug-delivery of water insoluble drugs. Langmuir. 2016;32:3217–3225.
  • Wouters BH, Chen T, Dewilde M, et al. Reactivity of the surface hydroxyl groups of MCM-41 towards silylation with trimethylchlorosilane. Micropor Mesopor Mater. 2001;44–45:453–457.
  • Saroj S, Rajput SJ. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide. Drug Dev Ind Pharm. 2018:44:1198–1211.
  • Yoncheva K, Popova M, Szegedi A, et al. Functionalized mesoporous silica nanoparticles for oral delivery of budesonide. J Sol State Chem. 2014;211:154–161.
  • de Oliveira Freitas LB, Bravo IJG, de Almeida Macedo WA, et al. Mesoporous silica materials functionalized with folic acid: preparation, characterization and release profile study with methotrexate. J Sol-Gel Sci Technol. 2016;77:186–204.
  • Salis A, Fanti M, Medda L, et al. Mesoporous silica nanoparticles functionalized with hyaluronic acid and chitosan biopolymers. Effect of functionalization on cell internalization. ACS Biomater Sci Eng. 2016;2:741–751.
  • Huo J, Aguilera-Sigalat J, El-Hankari S, et al. Magnetic MOF microreactors for recyclable size-selective biocatalysis. Chem Sci. 2015;6:1938–1943.
  • Summerlin N, Qu Z, Pujara N, et al. Colloidal mesoporous silica nanoparticles enhance the biological activity of resveratrol. Colloids Surf B Biointerfaces. 2016;144:1–7.
  • Daryasari MP, Akhgar MR, Mamashli F, et al. Chitosan-folate coated mesoporous silica nanoparticles as a smart and pH-sensitive system for curcumin delivery. Rsc Adv. 2016;6:105578–105588.
  • Li J, Zheng L, Cai H, et al. Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging. Biomaterials. 2013;34:8382–8392.
  • Gayam SR, Wu S-P. Redox responsive Pd (II) templated rotaxane nanovalve capped mesoporous silica nanoparticles: a folic acid mediated biocompatible cancer-targeted drug delivery system. J Mater Chem B. 2014;2:7009–7016.
  • Kim TH, Kim M, Park HS, et al. Size-dependent cellular toxicity of silver nanoparticles . J Biomed Mater Res A. 2012;100:1033–1043.
  • Sing KS. Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity (Recommendations 1984). Pure Appl Chem. 1985;57:603–619.
  • Yuan L, Wu Y, Fang J, et al. Modified alginate and gelatin cross-linked hydrogels for soft tissue adhesive. Artif Cells Nanomed Biotechnol. 2017;45:76–83.
  • Feng W, Nie W, He C, et al. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers. ACS Appl Mater Interfaces. 2014;6:8447–8460.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.